- Home
- OZ vs PALI Comparison
OZ vs PALI Comparison
Compare OZ & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- PALI
- Stock Information
- Founded
- OZ 2020
- PALI 1996
- Country
- OZ United States
- PALI United States
- Employees
- OZ N/A
- PALI N/A
- Industry
- OZ
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OZ
- PALI Health Care
- Exchange
- OZ Nasdaq
- PALI Nasdaq
- Market Cap
- OZ 234.8M
- PALI 212.0M
- IPO Year
- OZ N/A
- PALI N/A
- Fundamental
- Price
- OZ $67.99
- PALI $2.00
- Analyst Decision
- OZ
- PALI Strong Buy
- Analyst Count
- OZ 0
- PALI 2
- Target Price
- OZ N/A
- PALI $12.00
- AVG Volume (30 Days)
- OZ 3.4K
- PALI 7.1M
- Earning Date
- OZ 11-19-2025
- PALI 11-11-2025
- Dividend Yield
- OZ N/A
- PALI N/A
- EPS Growth
- OZ N/A
- PALI N/A
- EPS
- OZ N/A
- PALI N/A
- Revenue
- OZ $5,695,000.00
- PALI N/A
- Revenue This Year
- OZ N/A
- PALI N/A
- Revenue Next Year
- OZ N/A
- PALI N/A
- P/E Ratio
- OZ N/A
- PALI N/A
- Revenue Growth
- OZ 235.00
- PALI N/A
- 52 Week Low
- OZ $56.77
- PALI $0.53
- 52 Week High
- OZ $82.89
- PALI $3.30
- Technical
- Relative Strength Index (RSI)
- OZ 70.47
- PALI 60.77
- Support Level
- OZ $63.10
- PALI $1.61
- Resistance Level
- OZ $64.34
- PALI $2.14
- Average True Range (ATR)
- OZ 0.99
- PALI 0.19
- MACD
- OZ 0.40
- PALI -0.01
- Stochastic Oscillator
- OZ 99.85
- PALI 75.86
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.